Pranav S. Garimella, MD, MPH

Associate Professor of Clinical Medicine

Director, UC San Diego Acute Dialysis Services

Director, UC San Diego PKD Center of Excellence

Division of Nephrology and Hypertension

University of California San Diego

In person and via Zoom

Upon completion of this activity, participants will be able to:

• Apply age-dependent imaging criteria and genetic testing indications to accurately diagnose Autosomal Dominant Polycystic Kidney Disease (ADPKD) and distinguish it from other cystic kidney disorders.

• Stratify patients’ risk for rapid disease progression by utilizing Total Kidney Volume (TKV) measurements and the Mayo Imaging Classification to identify candidates for disease-modifying therapy.

• Formulate a comprehensive management plan that addresses blood pressure targets, the use of vasopressin V2 receptor antagonists, and the monitoring of extra-renal complications such as polycystic liver disease and intracranial aneurysms.

Disclosure of Financial Interest Summary

All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.

Pranav S. Garimella, MD, speaker for this educational event, is a consultant for Otsuka America Corp. 

All of the relevant financial relationships listed for these individuals have been mitigated

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.